THE ENDOCRINOLOGY OF LARGE-BOWEL CANCER

[1] Aaltonen L.A., Peltomaki P., Leach F.S., Vogelstein B., De La Chapelle A., Clues to the pathogenesis of familial colorectal cancer, Science, 260, pp. 812-816, (1993)

[2] Alford T.C., Hoan-My Do., Geelhold G.W., Steroid hormone receptors in human colon cancers, Cancer, 43, pp. 980-984, (1979)

[3] Anton-Culver H., Smoking and other risk factors associated with the stage and age of diagnosis of colon and rectum cancers, Cancer Detection and Prevention, 15, pp. 345-350, (1991)

[4] Attillasoy E., Holt P.R., Gastrointestinal proliferation and aging, Journal of Gerontology, 48, (1993)

[5] Barni S., Lissoni P., Cazzaniga M., Maestroni G., Neuroimmunotherapy with subcutaneous low-dose IL-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinoma, Tumori, 78, pp. 383-387, (1992)

[6] Baron J.A., Sandler R.S., Cigarette smoking and cancer of the large bowel, Smoking and Hormone-related Disorders, pp. 167-180, (1990)

[7] Bayerdorffer E., Increased risk of 'high-risk' colorectal adenomas in overweight men, Gastroenterology, 104, pp. 137-144, (1993)

[8] Bedenne L., Faivre J., Boutron M.C., Adenoma-carcinoma sequence or 'de novo' carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers, Cancer, 69, pp. 883-888, (1992)

[9] Bernstein C., Payne C., Garew H., Bile acid-induced DNA damage and apoptosis in the etiology of colon cancer, Proceedings of the American Association for Cancer Research, 35, (1994)

[10] Berstein L.M., Newborn macrosomy and cancer, Advances in Cancer Research, 50, pp. 231-278, (1988)

[1] Aaltonen L.A., Peltomaki P., Leach F.S., Vogelstein B., De La Chapelle A., Clues to the pathogenesis of familial colorectal cancer, Science, 260, pp. 812-816, (1993)

[2] Alford T.C., Hoan-My Do., Geelhold G.W., Steroid hormone receptors in human colon cancers, Cancer, 43, pp. 980-984, (1979)

[3] Anton-Culver H., Smoking and other risk factors associated with the stage and age of diagnosis of colon and rectum cancers, Cancer Detection and Prevention, 15, pp. 345-350, (1991)

[4] Attillasoy E., Holt P.R., Gastrointestinal proliferation and aging, Journal of Gerontology, 48, (1993)

[5] Barni S., Lissoni P., Cazzaniga M., Maestroni G., Neuroimmunotherapy with subcutaneous low-dose IL-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinoma, Tumori, 78, pp. 383-387, (1992)

[6] Baron J.A., Sandler R.S., Cigarette smoking and cancer of the large bowel, Smoking and Hormone-related Disorders, pp. 167-180, (1990)

[7] Bayerdorffer E., Increased risk of 'high-risk' colorectal adenomas in overweight men, Gastroenterology, 104, pp. 137-144, (1993)

[8] Bedenne L., Faivre J., Boutron M.C., Adenoma-carcinoma sequence or 'de novo' carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers, Cancer, 69, pp. 883-888, (1992)

[9] Bernstein C., Payne C., Garew H., Bile acid-induced DNA damage and apoptosis in the etiology of colon cancer, Proceedings of the American Association for Cancer Research, 35, (1994)

[10] Berstein L.M., Newborn macrosomy and cancer, Advances in Cancer Research, 50, pp. 231-278, (1988)